Blackmores

May 31, 2024

Lead the growth of the Health Science business by growing revenue
in each country and promoting the Kirin Group’s initiatives in creating added value

Lead the growth of the Health Science business by growing revenue in each country and promoting the Kirin Group’s initiatives in creating added value

2023 Review

Acquisition was finished in the second half of the year and projects for SCM, quality assurance, IT, ESG, organization culture, and more were established and reviewed toward creating added value. Furthermore, considerations of how to leverage KIRIN’s materials, such as LC-Plasma, are progressing as planned.
Normalized operating profit met original expectations.

Aim to raise revenue and profit in each region, Australia, New Zealand, SEAK,^* and China, to increase revenue. Utilize the value of top-share brands in Australia and New Zealand to improve revenue, while increasing profitability through price revisions and launching highly profitable products. Launch new products and make sales activities more efficient internationally. Aim to significantly grow the brand in China by growing its awareness through marketing investments.